These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

680 related items for PubMed ID: 16310764

  • 1. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B, Schoemaker RG, van Gilst WH, van Veldhuisen DJ, Buikema H.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):141-9. PubMed ID: 16310764
    [Abstract] [Full Text] [Related]

  • 2. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
    Sacco G, Mario B, Lopez G, Evangelista S, Manzini S, Maggi CA.
    Vascul Pharmacol; 2009 Dec 19; 50(5-6):166-70. PubMed ID: 19344651
    [Abstract] [Full Text] [Related]

  • 3. Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction.
    Westendorp B, Schoemaker RG, Buikema H, de Zeeuw D, van Veldhuisen DJ, van Gilst WH.
    J Renin Angiotensin Aldosterone Syst; 2004 Mar 19; 5(1):27-32. PubMed ID: 15136971
    [Abstract] [Full Text] [Related]

  • 4. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J, Ortiz MC, O'Valle F, Alcaraz A, Navarro EG, Vargas F, Evangelista S, Atucha NM.
    Clin Sci (Lond); 2006 Feb 19; 110(2):227-33. PubMed ID: 16197366
    [Abstract] [Full Text] [Related]

  • 5. Adverse renal effects of hydrochlorothiazide in rats with myocardial infarction treated with an ACE inhibitor.
    Westendorp B, Hamming I, Szymanski MK, Navis G, van Goor H, Buikema H, van Gilst WH, Schoemaker RG.
    Eur J Pharmacol; 2009 Jan 14; 602(2-3):373-9. PubMed ID: 19084001
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction.
    Ahmad M, White R, Tan J, Huang BS, Leenen FH.
    J Cardiovasc Pharmacol; 2008 Jun 14; 51(6):565-72. PubMed ID: 18496146
    [Abstract] [Full Text] [Related]

  • 7. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    Bralet J, Marie C, Mossiat C, Lecomte JM, Gros C, Schwartz JC.
    J Pharmacol Exp Ther; 1994 Jul 14; 270(1):8-14. PubMed ID: 8035346
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin-converting enzyme inhibition limits dysfunction in adjacent noninfarcted regions during left ventricular remodeling.
    Kramer CM, Ferrari VA, Rogers WJ, Theobald TM, Nance ML, Axel L, Reichek N.
    J Am Coll Cardiol; 1996 Jan 14; 27(1):211-7. PubMed ID: 8522697
    [Abstract] [Full Text] [Related]

  • 9. Effects of zofenopril on myocardial ischemia in post-myocardial infarction patients with preserved left ventricular function: the Survival of Myocardial Infarction Long-term Evaluation (SMILE)-ISCHEMIA study.
    Borghi C, Ambrosioni E, Survival of Myocardial Infarction Long-term Evaluation Study Group.
    Am Heart J; 2007 Mar 14; 153(3):445.e7-14. PubMed ID: 17307427
    [Abstract] [Full Text] [Related]

  • 10. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators.
    Ambrosioni E, Borghi C, Magnani B.
    N Engl J Med; 1995 Jan 12; 332(2):80-5. PubMed ID: 7990904
    [Abstract] [Full Text] [Related]

  • 11. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    Duncan AM, James GM, Anastasopoulos F, Kladis A, Briscoe TA, Campbell DJ.
    J Pharmacol Exp Ther; 1999 Apr 12; 289(1):295-303. PubMed ID: 10087017
    [Abstract] [Full Text] [Related]

  • 12. Zofenopril plus hydrochlorothiazide fixed combination in the treatment of hypertension and associated clinical conditions.
    Omboni S, Malacco E, Parati G.
    Cardiovasc Ther; 2009 Apr 12; 27(4):275-88. PubMed ID: 19832845
    [Abstract] [Full Text] [Related]

  • 13. The effects of short- and long-term treatment with an ACE-inhibitor in rats with myocardial infarction.
    Pinto YM, van Wijngaarden J, van Gilst WH, de Graeff PA, Wesseling H.
    Basic Res Cardiol; 1991 Apr 12; 86 Suppl 1():165-72. PubMed ID: 1827983
    [Abstract] [Full Text] [Related]

  • 14. An Angiotensin-converting enzyme inhibitor, zofenopril, prevents renal ischemia/reperfusion injury in rats.
    Altunoluk B, Soylemez H, Oguz F, Turkmen E, Fadillioglu E.
    Ann Clin Lab Sci; 2006 Apr 12; 36(3):326-32. PubMed ID: 16951275
    [Abstract] [Full Text] [Related]

  • 15. Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial.
    Latini R, Santoro E, Masson S, Tavazzi L, Maggioni AP, Franzosi MG, Barlera S, Calvillo L, Salio M, Staszewsky L, Labarta V, Tognoni G, GISSI-3 Investigators.
    Heart Dis; 2000 Apr 12; 2(3):185-90. PubMed ID: 11728260
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of matrix metalloproteinase-9 activity by lisinopril after myocardial infarction in hamsters.
    Takai S, Yamamoto D, Jin D, Inagaki S, Yoshikawa K, Tanaka K, Miyazaki M.
    Eur J Pharmacol; 2007 Jul 30; 568(1-3):231-3. PubMed ID: 17512521
    [Abstract] [Full Text] [Related]

  • 17. Serum cholesterol levels on admission and survival in patients with acute myocardial infarction treated with zofenopril: a post hoc analysis of the Survival of Myocardial Infarction Long-term Evaluation trial.
    Borghi C, Cicero AF, Bacchelli S, Esposti DD, Ambrosioni E, Survival of Myocardial Infarction Long-term Evaluation (SMILE) Study.
    Fundam Clin Pharmacol; 2009 Oct 30; 23(5):641-8. PubMed ID: 19656211
    [Abstract] [Full Text] [Related]

  • 18. Relation between myocardial beta-adrenoceptor density and hemodynamic and neurohumoral changes in a rat model of chronic myocardial infarction: effects of ibopamine and captopril.
    van Veldhuisen DJ, Brodde OE, van Gilst WH, Schulze C, Hegeman H, Anthonio RL, Scholtens E, de Graeff PA, Wesseling H, Lie KI.
    Cardiovasc Res; 1995 Sep 30; 30(3):386-93. PubMed ID: 7585830
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic and pharmacodynamic comparative study of zofenopril and enalapril in healthy volunteers.
    Marzo A, Dal Bo L, Mazzucchelli P, Monti NC, Crivelli F, Ismaili S, Giusti A, Uhr MR.
    Arzneimittelforschung; 2002 Sep 30; 52(4):233-42. PubMed ID: 12040965
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of Zofenopril Alone or in Combination with Hydrochlorothiazide in Patients with Kidney Dysfunction.
    Omboni S, Borghi C.
    Curr Clin Pharmacol; 2019 Sep 30; 14(1):5-15. PubMed ID: 30360726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.